# NITROFURANTOIN
> **ANDA217272** · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2023-03-21
## Drug
- **FDA Application Number:** ANDA217272
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROFURANTOIN
- **Generic name:** NITROFURANTOIN MACROCRYSTALS
- **Active ingredients:** NITROFURANTOIN, MACROCRYSTALLINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MANKIND PHARMA
- **Manufacturer:** Lifestar Pharma LLC
- **First approval:** 2023-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217272)
---
*AI Analytics · CC0 1.0*